1-7 of 7
Michael D. Hogarty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Navin Pinto, Arlene Naranjo, Xiangming Ding, Fan F. Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W. Craig, Zarko Manojlovic, Michael D. Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S. Irwin, Julie R. Park, Shahab Asgharzadeh
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (8): 1546–1556.
https://doi.org/10.1158/1078-0432.CCR-22-3032
Published: 14 April 2023
View articletitled, Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report
Open the PDF for Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report in another window
Includes: Supplementary data
Journal Articles

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquelyn A. Hank, Mitchell B. Diccianni, Ralph A. Reisfeld, Stephen D. Gillies, Katherine K. Matthay, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Julie R. Park, M. Fevzi Ozkaynak, Andrew L. Gilman, Alice L. Yu, Paul M. Sondel
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (1): 189–196.
https://doi.org/10.1158/1078-0432.CCR-17-1767
Published: 02 January 2018
View articletitled, Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Open the PDF for Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group in another window
Includes: Supplementary data
Journal Articles

Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

Nicholas F. Evageliou, Michelle Haber, Annette Vu, Theodore W. Laetsch, Jayne Murray, Laura D. Gamble, Ngan Ching Cheng, Kangning Liu, Megan Reese, Kelly A. Corrigan, David S. Ziegler, Hannah Webber, Candice S. Hayes, Bruce Pawel, Glenn M. Marshall, Huaqing Zhao, Susan K. Gilmour, Murray D. Norris, Michael D. Hogarty
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (17): 4391–4404.
https://doi.org/10.1158/1078-0432.CCR-15-2539
Published: 31 August 2016
View articletitled, Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Open the PDF for Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression in another window
Includes: Supplementary data
Journal Articles

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

Katleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, Fjoralba Zeka, Arlene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elzbieta Drozynska, Angelika Eggert, Michael D. Hogarty, Ewa Iżycka-Swieszewska, Wendy B. London, Rosa Noguera, Marta Piqueras, Kenneth Bryan, Benjamin Schowe, Peter van Sluis, Jan J. Molenaar, Alexander Schramm, Johannes H. Schulte, Raymond L. Stallings, Rogier Versteeg, Geneviève Laureys, Nadine Van Roy, Frank Speleman, Jo Vandesompele
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7684–7692.
https://doi.org/10.1158/1078-0432.CCR-11-0610
Published: 18 December 2011
View articletitled, miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
Open the PDF for miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples in another window
Includes: Supplementary data
Journal Articles

Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma

Nicholas F. Evageliou, Michael D. Hogarty
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 5956–5961.
https://doi.org/10.1158/1078-0432.CCR-08-3213
Published: 30 September 2009
View articletitled, Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
Open the PDF for Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma in another window
Journal Articles

Expression of a MYCN -interacting Isoform of the Tumor Suppressor BIN1 Is Reduced in Neuroblastomas with Unfavorable Biological Features

Tatsuro Tajiri, Xueyuan Liu, Patricia M. Thompson, Shinji Tanaka, Sachiyo Suita, Huaqing Zhao, John M. Maris, George C. Prendergast, Michael D. Hogarty
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3345–3355.
Published: 05 September 2003
View articletitled, Expression of a MYCN -interacting Isoform of the Tumor Suppressor BIN1 Is Reduced in Neuroblastomas with Unfavorable Biological Features
Open the PDF for Expression of a MYCN -interacting Isoform of the Tumor Suppressor BIN1 Is Reduced in Neuroblastomas with Unfavorable Biological Features in another window
Journal Articles

MYC Messenger RNA Expression Predicts Survival Outcome in Childhood Primitive Neuroectodermal Tumor/Medulloblastoma

Michael A. Grotzer, Michael D. Hogarty, Anna J. Janss, Xueyuan Liu, Huaquing Zhao, Angelika Eggert, Leslie N. Sutton, Lucy B. Rorke, Garrett M. Brodeur, Peter C. Phillips
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2425–2433.
Published: 01 August 2001
View articletitled, MYC Messenger RNA Expression Predicts Survival Outcome in Childhood Primitive Neuroectodermal Tumor/Medulloblastoma
Open the PDF for MYC Messenger RNA Expression Predicts Survival Outcome in Childhood Primitive Neuroectodermal Tumor/Medulloblastoma in another window